Translational Development Acquisition Company (NYSE: TDAC) ( "TDAC") announced that ProLogium has filed their initial F-4 with the SEC driving the companies forward towards a successful execution of ...
Translational Development Acquisition Corp. does not have significant operations. The company intends to effect a merger, amalgamation, share exchange, asset acquisition, share purchase, ...
Translational Development Acquisition Company (NYSE: TDAC) (the "Company" or "TDAC") announced the very successful results of the shareholder vote held on 6/17/26 regarding the proposed extension of ...
Translational (TDAC) stock analysis | earnings revisions, market trends, long-term upside potential. Translational ...
ProLogium Holding and Translational Development Acquisition Corp. (TDAC) have entered into a definitive agreement for a business combination that would result in ProLogium becoming a publicly listed ...
NEW YORK, June 22, 2026 /PRNewswire/ -- Translational Development Acquisition Company (NYSE: TDAC) (the "Company" or "TDAC") announced the very successful results of the shareholder vote held on ...
TDAC is trading in the middle of its 52-week range and above its 200-day simple moving average. Price change The price of TDAC shares has held flat since the market last closed. This is a 0.00% change ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results